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Background: Proline-rich segments in the guanine
nucleotide exchange factor C3G bind much more
strongly to the N-terminal Src homology 3 domain
(SH3-N) of the proto-oncogene product c-Crk than to
other SH3 domains. The presence of a lysine instead of an
arginine in the peptides derived from C3G appears to be
crucial for this specificity towards c-Crk.
Results: In order to understand the chemical basis of this
specificity we have determined the crystal structure of
Crk SH3-N in complex with a high affinity peptide from
C3G (PPPALPPKKR, Kd -2 M) at 1.5 A resolution.
The peptide adopts a polyproline type II helix that binds,
as dictated by electrostatic complementarity, in reversed
orientation relative to the orientation seen in the earliest
structures of SH3-peptide complexes. A lysine in the
C3G peptide is tightly coordinated by three acidic
residues in the SH3 domain. In contrast, the co-crystal
structure of c-Crk SH3-N and a peptide containing an
arginine at the equivalent position (determined at 1.9 A
resolution) reveals non-optimal geometry for the arginine
and increased disorder.
Conclusions: The c-Crk SH3 domain engages in an
unusual lysine-specific interaction that is rarely seen in
protein structures, and which appears to be a key deter-
minant of its unique ability to bind the C3G peptides
with high affinity.
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Introduction
The viral oncogene product Crk was the first member of
the family of 'adapter proteins' to be discovered [1,2].
These proteins are important in cellular signal transduc-
tion. The surprising aspect of the discovery of Crk was
the realization that despite its ability to transform cells and
to modulate the activity of tyrosine kinases, it contains
only modular units known as SH2 and SH3 domains (Src
homology domains) that have no intrinsic catalytic or
transcriptional activity [3]. It is now well established that
the functions of adapter proteins are indeed a conse-
quence of the SH2 and SH3 domains, which mediate
protein-protein interactions via recognition of phospho-
rylated tyrosines and proline-rich sequences, respectively
[2,4-6]. Other members of this family include Nck, and
the various homologs of Grb2/Sem5 [6]. These proteins
form multi-dentate complexes with diverse signalling pro-
teins in response to external stimuli, and serve to localize
these proteins at the sites of receptor phosphorylation.
This has been demonstrated most clearly for Grb2/Sem5,
which binds to tyrosine-phosphorylated proteins at the
cell membrane mediated by its SH2 domain and, simulta-
neously, to the guanine nucleotide exchange factor, Sos,
through its SH3 domain. Membrane localization of Sos
results in the activation of Ras (for a review, see [2]).
The cellular form of the Crk protein (c-Crk) consists of
an SH2 domain followed by two SH3 domains [7].
Screening of expression libraries for proteins that bind to
the SH3 domains of c-Crk led to the identification of
C3G, a 145-155 kDa protein that contains a region of
homology to Ras guanine nucleotide exchange factors as
well as a segment containing four homologous proline-
rich stretches incorporating the PXXP motifs [8] that are
characteristic of SH3 targets [9,10]. The interaction with
C3G is mediated entirely by the N-terminal SH3
domain of c-Crk (SH3-N), which is quite divergent in
sequence from the C-terminal SH3 domain. c-Crk is
also known to bind to other proteins, such as Sos and the
tyrosine kinases Abl and Arg, via its SH3 domains
[11,12]. Alignment of proline-rich sequences from these
Crk-binding proteins resulted in a preliminary consensus
for c-Crk SH3-N binding: PXLPXK/R. Peptides from
C3G, Abl and Arg contain lysine at the last position,
whereas those from Sos contain arginine [10]. Despite
the apparent similarity in their proline-rich SH3-binding
sequences, C3G binds selectively to the c-Crk SH3-N
domain whereas Sos binds to the SH3 domains of c-Crk,
Grb2, Src and Nck.
In a filter-binding assay using the proline-rich segment
of C3G fused to glutathione S-transferase (GST), the
SH3 domains of Nck, Src, Abl, phospholipase Cy and
spectrin were unable to bind to the C3G segment [10].
The SH3 domains of Grb2 and the p85 subunit of phos-
phatidyl-inositol 3-kinase bound weakly to C3G in the
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filter-binding assays [9,10], but would not precipitate
from solution in enzyme-linked immunosorbent assays
[10]. Quantitative measurement of the interaction
between various proline-rich peptides and SH3 domains
by fluorescence spectroscopy has revealed that the high
affinity C3G peptide, PPPALPPKKR (referred to as
C3G in this paper), binds to the c-Crk SH3-N domain
with a dissociation constant (Kd) of 1.9 M, which is
one of the highest affinities reported for an SH3 domain
(Table 1) (B Knudsen et al., unpublished data). The C3G
peptide binds much more weakly to the Grb2 N-termi-
nal SH3 domain, with a Kd of 142 IM. In contrast, a
peptide from Sos which binds tightly to the c-Crk
SH3-N domain (PPPVPPRRRR, referred to as Sos;
Kd=5.2 iM) also binds tightly to Grb2 (Kd= 3 .5 RIM)
(B Knudsen et al., unpublished data).
The promiscuity displayed by the Sos peptide is typical
of SH3-binding peptides, which most often only dis-
criminate between broad classes of SH3 domains and
rarely manifest the more specific discrimination shown
by the C3G peptides. Mutagenesis of the C3G peptide
showed that the presence of a lysine rather than an argi-
nine as the first basic residue following the PXXP
motifs is crucial for this specificity (B Knudsen et al.,
unpublished data). Replacement of the first lysine by
arginine in the C3G peptide, keeping everything else
the same, reduces the affinity for c-Crk SH3-N by a
factor of nine (Kd=17 .2 iM) and significantly increases
the affinity for Grb2 SH3-N (Kd=2 7.9 RM), leading to
loss of specificity (Table 1). The critical role played by a
lysine residue in the determination of specificity is
noteworthy, because arginine rather than lysine is usu-
ally the residue of choice for the formation of electro-
static interactions with high specificity. Interestingly, the
SH3 domain of the viral form of Crk, v-Crk, which
differs from c-Crk SH3-N only at two amino acid posi-
tions, is not sensitive to the presence of arginine versus
lysine in the peptides. This indicates that a particular
localized interaction underlies the ability of c-Crk
SH3-N to preferentially bind to the lysine-containing
peptides. We therefore initiated a project to obtain
high-resolution crystal structures of peptide complexes
of the c-Crk SH3 domain in order to understand the
mode of peptide binding in general and the role of the
lysine in particular.
The general features of SH3 structure and the interac-
tion with proline-rich peptides are now understood
[5,13]. The structures of a number of uncomplexed
SH3 domains have been determined and have estab-
lished a highly conserved fold consisting of two anti-
parallel 3-sheets packed against each other (reviewed
in [5]). The discovery that SH3 domains bind to
sequences that contain multiple prolines with character-
istic PXXP motifs [8,14] was followed by the proposal
that the SH3 surface could recognize a polyproline type
II helix [15] and by the determination of the three-
dimensional structures of peptide complexes of the p85
SH3 domain by NMR [16] and the Abl and Fyn SH3
domains by X-ray crystallography [17]. These first struc-
tures of SH3 complexes revealed that a conserved set of
residues on the SH3 surface provide hydrophobic inter-
actions with side chains presented by the polyproline
type II helix.
In each of these structures, the peptide bound in the
same 'plus' orientation. While this manuscript was in
preparation,, four papers have been published that
describe the interaction of proline-rich peptides with the
Src SH3 domain [18] and with the SH3 domains of
mammalian Grb2 [19,20] and its Caenorhabditis elegans
homolog Sem-5 [21]. The structures of Src SH3 domain
bound to two peptides obtained by selection from a
combinatorial library revealed that whereas one peptide
bound in the 'plus' orientation, the other bound in the
opposite, 'minus', orientation. The three structures of
Grb2/Sem-5 SH3 domains show that the Sos peptides
bind in the 'minus' orientation. The ability of different
proline-rich peptides to bind in opposite orientations to
the same binding sites on the SH3 surface can be under-
stood in terms of the symmetry of the polyproline helix
and the specific electrostatic and hydrophobic packing
interactions observed in these complexes. Analyses of
these structures have led to the enunciation of general
rules for describing the mode of binding of proline-rich
peptides to SH3 domains [18,21].
In these recent structures of the Src [18] and
Grb2/Sem5 [19-21] peptide complexes, the orientation
of the peptide is determined primarily by electrostatic
interactions between arginine residues in the peptide
and acidic residues localized at one end of the peptide-
binding surface of the SH3 domains. Many SH3
domains have acidic residues in this region. For exam-
ple, most SH3 domains have a glutamate or aspartate
residue, corresponding to Glu172 in Sem-5, that is
observed to hydrogen bond to an arginine residue in the
Sos peptide [21]. Likewise, the central interactions
mediated by PXXP motifs involve highly conserved
Table 1. Binding affinities of proline-rich peptides for the SH3 domains of
of c-Crk (N-terminal domain), v-Crk and Grb2 (N-terminal domain).
Kd (pM)
c-Crk v-Crk Grb2
Peptide SH3-N SH3 SH3-N
C3G P P P A L P P K K R 1.9 25.5 142.0
Sos P P P V P P R R R R 5.2 23.7 3.5
C3G (mutant) P P P A L P P R K R 17.2 23.5 27.9
Data are taken from an extensive study of peptide binding to the Crk SH3 do-
main, carried out by Knudsen et al. (unpublished data). The data shown are for
glutathione S-transferase-SH3 fusion proteins, and are obtained by measure-
ment of the changes in intrinsic tryptophan fluorescence upon peptide binding.
Very similar results are obtained with the isolated Crk SH3 domain used in the
crystallographic study (data not shown). All measurements were carried out in
phosphate buffered saline at 18°C. Sites that differ from the C3G peptide are
shown in bold.
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hydrophobic residues in the SH3 domains. Conse-
quently, the basis for sequence discrimination between
proline-rich peptides and particular SH3 domains
requires further elaboration.
Here we present high-resolution crystal structures of
c-Crk SH3-N bound to two high affinity peptides, one
from C3G and one from Sos. Both peptides bind in the
minus orientation, and the general features of the peptide
interaction are very similar to those seen for Sos peptides
bound to Grb2/Sem5 [19-21]. However, comparison of
the interactions between the c-Crk SH3 domain and a
lysine (in the C3G peptide) and an arginine (in the Sos
peptide) sheds light on the structural basis for the prefer-
ential binding of c-Crk SH3-N to C3G and illustrates
how subtle variations in the structure of a conserved
interface can lead to binding specificity.
Results and discussion
Structures of c-Crk SH3-N in complex with C3G and Sos
peptides
Crystals of the two peptides bound to c-Crk diffract to
very high resolution, and the datasets used have been
limited to Bragg spacings of 1.5 A and 1.9 A for the
C3G and Sos complexes, respectively, by experimental
constraints such as the time available for data collection.
Fig. la shows electron density at 1.5 A resolution for the
C3G peptide bound to the c-Crk SH3 domain. Strong
density is seen for the first eight residues of the peptide
(PPPALPPK) and somewhat weaker density for the
lysine at position 9. The C-terminal arginine is disor-
dered and not visible in the electron density. The pep-
tide adopts a left-handed polyproline type II helix over
most of its length (Fig. lb, Table 2), and is bound with
the C-terminal residues near the RT loop (so called
Fig. 1. (a) Difference electron-density
map for the C3G peptide bound to
c-Crk SH3-N. The C3G peptide was
removed from the final model of the
Crk-C3G complex and an electron-
density map was calculated using
(Fo-F c ) coefficients and model phases,
using data between 10.0 A and 1.5 A
spacings. Positional refinement without
peptide (100 steps) preceded the calcu-
lation of the map. Electron-density
contours at the 2.0a (in blue) and 4.0to(in red) levels are shown. The C3G
peptide is shown in yellow within the
density, with Pro2, Leu5 and Lys8
residues labeled. The backbone of c-Crk
SH3-N is represented as a ribbon.
Acidic side chains are red, basic side
chains are blue, polar side chains are
yellow and non-polar side chains are
white. (b) Stereo diagram of the c-Crk
SH3-N domain in complex with the
C3G peptide (PPPALPPKKR). The Ca
backbone of the SH3 domain is shown,
as well as a ball-and-stick representa-
tion of the C3G peptide. Every tenth
residue in the SH3 domain is
numbered, and Pro2, Leu5 and Lys8 of
C3G are labeled. (Figure generated
using MOLSCRIPT [47].)
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because this loop in the tyrosine kinase Src contains
critical arginine and threonine residues) and the n-Src
loop (the site of an insertion in the sequence of neu-
ronal Src) (Fig. 1). A striking aspect of the electron den-
sity is that the strongest density features associated with
the peptide are for the lysine side chain at position 8.
The electron density is stronger for the terminal atoms
of the side chain than for the backbone, indicating
unusually tight interactions between the lysine and the
SH3 domain.
The overall fold of the c-Crk SH3-N domain is very
similar to that of other SH3 domains. In particular,
comparison with the crystal structures of the SH3
domains of spectrin [22], Fyn [23], Lck [24], Abl [17]
and Nck (X Wu and J Kuriyan, unpublished data),
results in root mean square (rms) deviations in Ca posi-
tions between the c-Crk and other SH3 domains of
-0.5 A-0.6 A for the secondary-structural elements
(deviations are larger for the structures determined by
NMR). The only regions with significant structural dif-
ference are the loops connecting the 13-strands, in par-
ticular the RT and n-Src loops that are involved in
peptide recognition (Fig. 2).
Fig. 3 shows a schematic diagram of the C3G peptide as
bound to the c-Crk SH3 domain. For consistency, we
adopt the notation used previously [21], and refer to
sites on the polyproline helix as P-l, P0 , P+1 etc., where
Leu5 in the C3G peptide occupies the P0 position (Fig.
3). Using this notation, there are six binding sites for the
peptide on the c-Crk SH3 surface, corresponding to P+3
(Pro2 in C3G), P+2 (Pro3), P0 (Leu5), P-1 (Pro6), P-3
(Lys8) and P 4 (Lys9). The requirement for proline
residues at certain positions in the peptide has been
explained by considering the disposition of non-proline
side chains with respect to the SH3 surface at various
positions along the polyproline type II helix [18,21].
The polyproline helix has a triangular cross-section, and
side chains along two of the edges interact with the sur-
face of the SH3 domain. Non-proline side chains along
one edge tend to adopt conformations that extend away
from the SH3 surface, leading to poorer interactions
(referred to as 'external packing' [21]). Proline side
chains at this edge pack well against the SH3 surface.
Non-proline side chains on the other edge of the helix
point into the SH3 surface, and can replace proline at
these positions (referred to as 'internal packing' [21]).
The third edge of the helix points away from the SH3
surface and can be substituted with non-proline residues,
although proline may be favored here to increase the
proline content of the peptides with consequent stabi-
lization of the helix. The characteristic PXXP motif that
is a feature of SH3 target sites is thus seen to result from
the need to preserve proline residues at sites of external
packing, and the positions of the prolines will differ
depending.on the orientation of the peptide [18,21]. For
C3G bound to c-Crk SH3, sites P+2 and P-1 correspond
to external packing positions and have proline residues.
The sites at P+3, Po and P-3 correspond to internal pack-
ing positions, and are occupied by a proline, a leucine
and a lysine, respectively (Fig. 3).
Interactions between the C3G peptide and the SH3
domain are illustrated in Fig. 4a. The peptide residues at
positions P_l, P0 , P+2 and P+3 are closely packed against
conserved hydrophobic residues in the SH3 domain
(Phel41, Phel43, Prol83, Tyr186, Trpl69 and Prol85).
There are three prominent ridges formed on the surface
of the SH3 domain by the side chains of these hydro-
phobic groups (Fig. 4b), and their spacing is such that a
close fit arises between the side chains presented by the
polyproline helix and the SH3 surface [15], resulting in
the burial of 670 A2 of surface area on the peptide and
450 A2 on the SH3 domain. These interactions are very
similar to those observed in the Src and Grb2/Sos
complexes in the minus orientation [19-21].
The ability of the polyproline helix to make equivalent
hydrophobic interactions in either orientation is reflected
by the close overlap between the residues at the P0 , P+2
and P+3 sites in the structure of the Abl SH3 domain in
complex with a peptide from the 3BP1 protein (bound
in the plus orientation) [17], and corresponding residues
in the C3G peptide (Fig. 2). However, the Abl/3BP1
and c-Crk/C3G structures diverge significantly at the P-3
site and beyond because of fundamentally different inter-
actions in this region. The cleft between the RT and
Table 2. Backbone torsion angles and structural deviations in the C3G
and Sos peptides.
Position Peptide Residue t V Deviation Deviation
from ideal between C3G
PPII helix (A) and Sos (A)
P4 C3G Proline ND 161.1 4.74
P3 C3G Proline -62.9 168.9 2.49 0.59
Sos Proline ND 166.8 1.56
P2 C3G Proline -78.8 175.6 0.35 0.35
Sos Proline -71.2 164.6 0.38
P1 C3G Alanine -60.4 138.8 0.24 0.61
Sos Proline -64.4 137.7 0.37
P0 C3G Leucine -81.9 124.2 0.27 0.48
Sos Valine -81.3 121.0 0.35
P_1 C3G Proline -68.4 152.7 0.26 0.42
Sos Proline -61.9 150.0 0.29
P-2 C3G Proline -70.8 151.9 0.07 0.35
Sos Proline -68.9 160.6 0.09
P- 3 C3G Lysine -91.5 143.0 0.67 0.28
Sos Arginine -97.5 160.3 0.43
P.4 C3G Lysine -118.4 ND 0.40 0.41
Sos Arginine ND 0.40
The positions in the polyproline helix are shown in Fig. 3. The b and ut angles
for an ideal polyproline type II (PPII) helix are -78- and +149, respectively
[461. An ideal PPII helix was generated and aligned with the central residues
(P1 to P-2) of the C3G and Sos helices, respectively. The deviations in Ca posi-
tions between the ideal and actual helices are shown. The last column shows
the deviations in Ca positions between the C3G and Sos peptides after the
protein structures are superimposed by least-squares. ND, not determined.
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Fig. 2. Comparison of various uncomplexed and peptide-complexed SH3 structures determined by X-ray crystallography. The Ca back-
bone of a number of SH3 domains, aligned by least-squares superposition, are shown in this figure. The uncomplexed SH3 domains
are from Fyn [231, Lck [24], spectrin [22] and Nck (X Wu and J Kuriyan, unpublished data) (all in yellow) and the three complexed
SH3 structures are c-Crk SH3/C3G (in red), c-Crk SH3/Sos (in white) and Abl SH3/3BP1 (in green), [171. To emphasize the reversed
orientation of the C3G and Sos peptides with respect to the 3BP1 peptide, their N and C termini are labeled.
Fig. 3. Schematic diagram showing interactions between the
C3G peptide and the c-Crk SH3-N domain. The C3G peptide is
represented by the left-handed shaded ribbon, and peptide
residues that interact with the SH3 domain are indicated by
shaded circles. Residues in c-Crk SH3-N that interact with the
peptide are indicated by oval boxes (for hydrophobic residues)
and rectangular boxes (for acidic residues). Distances (in A)
between interacting residues are shown for the nearest pair of
carbon atoms (for hydrophobic interactions) and between donor
atom and acceptor atom for hydrogen bonds.
n-Src loops in Abl is hydrophobic, allowing the N-ter-
minal hydrophobic region of the 3BP1 peptide to wrap
around the SH3 domain in a non-helical conformation
[17]. The presence of five acidic residues in the RT and
n-Src loops of the c-Crk SH3 domain would prevent the
hydrophobic N terminus of the peptide from interacting
in this region. Instead, the two lysines in the peptide are
bound here, and make a number of hydrogen-bonding
and packing interactions (Fig. 4).
The Sos peptide is bound to c-Crk SH3-N in a very
similar conformation as seen for the C3G peptide. There
are six differences in amino acid sequence between the
two peptides. The proline at position P+4 in C3G is
missing in Sos, proline is substituted for alanine at P+l,
valine for leucine at P0, arginine for lysine at P-3 and P-2
and an extra arginine is present after P_4' The deviations
in Cot positions between the two peptides are in the
range from -0.3-0.6 A (Table 2), after the protein struc-
tures have been superimposed. Deformations in the Sos
peptide with respect to the C3G peptide around the P0
site result in a movement of the valine (in Sos) towards
the SH3 surface, so that interactions are similar to those
seen for the leucine side chain in C3G. Both structures
overlap reasonably well with an ideal polyproline type II
helix (Table 2). If the residues at positions P to P 2 are
superimposed upon the ideal helix, the deviations in Co
positions between the ideal and actual helices are in the
range 0.07-0.37 A for these residues. The ends of the
peptide are distorted away from the ideal helix by as
much as 2.5 A (Table 2), with the distortions resulting in
an increase in the interactions with the SH3 surface.
Lysine-specific interactions with the C3G peptide
There are four acidic residues in the RT loop of the
murine c-Crk SH3-N domain: Asp147, Glu148, Glu149,
and Asp150. Of these, Glu148 points away from the pep-
tide and does not participate directly in binding interac-
tions. The other three residues approach each other
closely, and present three oxygen atoms that form a nearly
equilateral triangle (oxygen-oxygen distances in the range
4.3-4.6 A), with the lysine nitrogen at the geometric cen-
ter and at a distance of 1.0 A from the plane of the oxy-
gens (nitrogen-oxygen distances in the range 2.7-2.8 A).
The binding site is thus remarkably well suited for interac-
tion with lysine, since each of the three protons of the sp3
hybridized amino group can be donated to carboxylate
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Fig. 4. The interface between c-Crk SH3-N domain and the C3G peptide. (a) Important hydrophobic and polar interactions between c-
Crk SH3-N and the C3G peptide. The polypeptide backbone of the SH3 domain is represented by a green ribbon, and SH3 side chains
that interact with the peptide are colored red for acidic residues and white for hydrophobic residues. The RT and n-Src loops flanking
the C-terminal region of the C3G peptide are labeled. The C3G peptide is colored yellow, except for Lys8 and Lys9, which are colored
blue. The van der Waals surfaces of Lys8 (in C3G) and Trp169 (in Crk) are indicated by small dots. Hydrogen bonds associated with the
side chains of the C3G peptide are indicated by dashed white lines, and hydrogen bonds made to the backbone of C3G are drawn in
blue. [Figure generated using QUANTA (Molecular Simulations, Inc.).] (b) The molecular surface of the c-Crk/C3G complex, calcu-
lated with the peptide removed and displayed using GRASP [48]. The surface is colored according to the local electrostatic potential
calculated in the absence of peptide, assuming a 0.10 M NaCI concentration in the solvent. Note the negatively charged pocket (red)
surrounding the Lys8 side chain of the C3G peptide and the neutral region (gray) interacting with Pro2-Pro6 of C3G. The hydrophobic
side chains underneath the SH3 surface are displayed in green. The orientation in (b) is the same as in (a), for ease of identification of
the residues.
Fig. 5. Schematic diagram of the stereochemistry of the
lysine-carboxylate interaction at position P_3 (after Ippolito et al.[26]). The amino group of the peptide lysine is shown in a
Newman projection, and the relative disposition of the carboxy-
late groups and the hydrogen-bonding hydrogens in the C3G/Crk
complex are shown.
oxygens from Asp147, Glu149 and Asp 150 (Fig. 5). A sta-
ble interaction results, as suggested by the very high elec-
tron density level for the atoms of the lysine side chain
(Fig. 1) and by the low temperature factor of the terminal
nitrogen atom (6.3 A2 compared with the side chain aver-
age of 18 A2) and the oxygen atoms nearest to the nitrogen
(6.3 A2 for Asp150, 13.5 A2 for both Asp147 and Glu149).
The lysine is in a fully extended conformation, and it
approaches the triad of oxygen atoms directly from above
(Fig. 4), leading to near-optimal geometry for simultane-
ous hydrogen bonding in the trans, gauche+, and gauche-
orientations (Fig. 5). In particular, each of the nitrogen-
hydrogen bonds is almost coplanar with the correspond-
ing carboxyl group, and the hydrogen-oxygen distances
are within the range expected for tight hydrogen-bond-
ing interactions (-1.8 A [25]). One feature that is some-
what less than optimal is that nitrogen-hydrogen bonds
approach residues Asp147 and Glu149 in the slightly less
favored anti rather than syn orientation (Fig. 5) [26].
However, the carbon-oxygen-hydrogen angles are con-
sistent with the appropriate interactions between the
hydrogen and the lone pair electrons of the oxygen in
either the syn or anti orientation [26].
This precise alignment of the lysine appears to be main-
tained by other interactions between the peptide and the
Asp 150
Asp 14
H
Lys 8 in C3G peptide
Ca-
I
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SH3 domain. The polypeptide backbone of the peptide
is held in place by the formation of a hydrogen bond
between the side chain of Glu166 and the backbone
amide nitrogen at position 9 of the peptide, and by a
conserved hydrogen bond [21] between the side chain
nitrogen of Trp169 and the peptide carbonyl group at
position 6 (Fig. 4). In addition, the methylene groups of
the lysine side chain are tightly packed against the
hydrophobic surface of the side chain of Trpl69 (Fig. 4),
with carbon-carbon distances of-3.5 A.
The lysine-carboxylate interaction is rarely seen in protein
structures
The formation of simultaneous hydrogen bonds between
a lysine side chain and three carboxylate groups appeared
to us to be an uncommon interaction, and so a system-
atic search of the entire protein databank was carried out
for other instances of this interaction. For the purposes of
this search, the 'Lys/30' motif was defined as a cluster
formed by the terminal nitrogen atom from a lysine side
chain (the N5 atom), and three oxygen atoms from the
carboxylate groups of different aspartate or glutamate side
chains. The only geometric constraint placed on the
search was that the three distances between the N5 and
oxygen atoms be <3.7 A. All instances of this motif in all
2943 release and pre-release coordinate sets deposited in
the Brookhaven Protein Databank [27] on November 1,
1994, were found by brute-force search. No attempt was
made to generate multi-subunit complexes from the
symmetry operations given for some coordinate sets,
although inter-subunit interactions within an asymmetric
unit are included. The proteins with the Lys/30 motif
were organized into families such that any two proteins
from the same and different families had greater than or
less than 30% sequence identity, respectively. Only one
representative protein structure from each family was
retained for further analysis.
This search of the entire contents of the protein data-
bank resulted in the identification of only 10 unique
protein structures in which a lysine amino nitrogen has
hydrogen-bonding interactions with three carboxyl
oxygens, confirming that this motif is indeed extremely
rare. The 10 structures identified by this search are:
glycogen phosphorylase (for example, protein databank
entry labb [28]), HIV reverse transcriptase (entry 3hvt
[29]), aspartate aminotransferase (entry lasn [30]), mengo
virus coat protein (entry 2mev [31]), chloromuconate
cycloisomerase or muconate lactonizing enzyme (entry
lchr [32]), the nitrogenase Mo-Fe protein (entry lmin
[33]), chorismate mutase (entry 2cht [34]), xylose iso-
merase mutant (entry lxyl [35]), enolase (entry 4enl [36])
and actinidin (entry laec [37]). A detailed examination of
these 10 structures revealed that in many cases the lysine
is part of a network of basic and acidic residues that
does not quite resemble the Lys-Glu-Asp interaction seen
in the SH3 domain. In two others, there are clusters that
resemble the SH3 Lys/30 motif (3hvt and 2cht), but
they are in regions of the protein with high temper-
ature factors. The cluster in actinidin does resemble the
SH3 case closely, but here the lysine (Lysl7) has four
potential ligands, including three glutamates and one
serine, and an additional lysine coordinates one of the
glutamates [37].
It is not surprising to find that protein structures avoid
bringing together three carboxyl groups without more
than one compensating basic residue nearby. Indeed, the
closest analogy to the SH3-lysine interaction may be the
structure of a mutant xylose isomerase, with the lysine
replacing the magnesium ion at a metal-binding site of the
enzyme [35] (Fig. 6). In an interesting protein engineer-
ing experiment, a glutamate residue that is required for
metal coordination in xylose isomerase was mutated to
lysine, in order to abolish metal binding. Little structural
change is induced in the protein as a consequence of this
mutation, and the amino group of the lysine replaces the
magnesium ion and coordinates two aspartate side chains
and one glutamate side chain [35]. Although there is strik-
ing similarity between this interaction and that observed
in the SH3-C3G complex, it is interesting to note that
the orientation of the lysine residue in the mutant xylose
Fig. 6. Comparison of the lysine-binding
site in Crk to a metal-binding site in
xylose isomerase. In each of the panels,
residues of interest are shown as stick
figures, the protein backbone is shown
as a blue ribbon, and hydrogen bonds
and metal coordination are indicated by
broken lines. (a) A Mg2+-binding site in
wild-type xylose isomerase (protein data-
bank entry, lxya, [351). (b) The lysine-
specific interactions in a mutant xylose
isomerase are shown, in which the
Glu180 was changed to a lysine (entry
1 xyl, [35]). Both structures of xylose iso-
merase were determined at 1.8 A resolu-
tion. (c) The lysine-specific interactions
in the Crk/C3G complex. The red ribbon
represents the peptide backbone and the
blue ribbon represents the SH3 back-.
bone. Note the extended conformation of the lysine and the fact that it approaches the triad of carboxylate groups from directly above,
thus allowing the formation of a more optimal hydrogen-bonding network in Crk/C3G than seen in the xylose isomerase mutant.
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isomerase is not as optimal as in the SH3 domain, because
it approaches the triad of carboxylate groups at an angle
and is not in a fully extended conformation (Fig. 6).
Interaction with arginine at position P-3 in the Sos peptide
The binding mode of the Sos peptide is very similar to
that seen with the C3G peptide (Fig. 2) and the arginine
side chain at P 3 extends across the face of the Trpl69
side chain and interacts with the acidic residues in the
RT loop. However, a notable difference is that in contrast
to lysine, the arginine side chain is not well ordered and
does not adopt an optimal conformation for hydrogen-
bonding interactions with the acidic groups or for
hydrophobic interactions with the tryptophan side chain.
One terminal nitrogen of the arginine side chain makes a
strong hydrogen bond with Asp150 (nitrogen-oxygen
distance of 2.4 A). The second nitrogen interacts less
optimally with Asp147 (nitrogen-oxygen distance of
3.1 A), and the imino nitrogen is not involved in hydro-
gen-bonding interactions with the protein. Unlike the
lysine in the C3G peptide, the arginine in Sos does not
adopt a low energy extended conformation (the X3 tor-
sion angle is in a gauche conformation) and does not pack
tightly against the tryptophan (the closest van der Waals
contact is 4.2 A, in contrast to 3.5 A in C3G). Finally,
electron density for the arginine side chain is relatively
weak, indicating conformational flexibility.
The extent of conformational disorder in the two pep-
tide complexes was estimated by carrying out a number
of independent crystallographic refinements of the struc-
tures after the introduction of random perturbations in
the atomic positions (Fig. 7) [38]. In order to make the
comparisons meaningful, these refinements were carried
out using data to 1.9 A spacings for both complexes.
Atomic positions in the RT loop and the P_3 position of
the peptide were randomly displaced such that the rms
deviation from the starting model was -1.7 A. Many
perturbed structures were generated independently in
this way, and subjected to crystallographic least-squares
refinement. In order to increase the radius of conver-
gence of the procedure, the refinements were initiated at
3.5 A, with the resolution limit being gradually
increased to 1.9 A during the course of the refinement.
Excessive shifts in water molecule positions were
avoided by restraining the water oxygens to their origi-
nal positions by a harmonic constant. A total of 1000
steps of conjugate-gradient optimization were carried
out. Refinements that failed to converge to R-values
within 0.3 percentile points of the original value were
rejected. A set of 24 structures was generated in this way
for each of the two peptide complexes. A more exhaus-
tive search procedure would involve simulated annealing
and multiple conformers for the protein [38], but this
was not attempted.
Despite the relatively large random shifts introduced
into the structures prior to refinement, the amino group
of the lysine as well as the carboxylate groups of the
three acidic side chains in the c-Crk/C3G complex
Fig. 7. Results of multiple refinements of
the structures of (a) the c-Crk/C3G com-
plex and (b) the c-Crk/Sos complex. To
estimate the structural uncertainties
associated with the lysine and arginine
interactions, the coordinates of residues
147-150 (the RT loop) of Crk SH3 and
Lys8 at P_3 in C3G peptide (Arg7 at P_3
in Sos peptide) of the final structure
were repeatedly perturbed by random
displacements, resulting in an rms devi-
ation of 1.7 A from the original model.
The resulting structures were indepen-
dently refined, using data to 1.9 A for c-
Crk/C3G and c-Crk/Sos. The results of
24 independent refinements for each
structure are shown. All the structures
shown have R-values that are compara-
ble with the original structure (see text).
Hydrogen bonds are indicated by
dashed lines. Oxygen atoms are colored
red, nitrogens, blue and carbons, white.
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Fig. 8. Sequence alignment of several SH3 domains. The sequences of different SH3 domains are aligned based on the secondary
structure. The top line provides the notations for secondary structure: 'b' for p-sheet and 30 for 310-helix. The most highly conserved
residues that interact with the ligand are in bold-faced type. Residues that are conserved in many SH3 domains and that interact with
the ligand are underlined. The residues in italics represent those that are specific for c-Crk SH3 and closely related domains. The SH3
sequences shown are as follows. crk-N: mouse c-Crk, N-terminal SH3 domain (residues 134-191; Genbank accession s72408) [49].
v-Crk: viral Gag-Crk oncogene product from the CT10 virus (residues 370-426; Genbank accession Y00302) [1]. Crkl: human Crk-
like protein, N-terminal SH3 domain (residues 125-181; Genbank accession X59656) [50]. Nck-N: human Nck protein, N-terminal
SH3 domain (residues 2-62; Genbank accession X17576) [51]. Lck: human Lck tyrosine kinase (residues 51-119; Genbank accession
M36881) [24]. Fyn: human Fyn tyrosine kinase (residues 84-142) [231. Spec: chicken spectrin (residues 2-62) [22]. Abl: Abl tyrosine
kinase (residues 84-141; Genbank accession U07563) [17]. Grb2-N: human Grb2 protein, N-terminal SH3 domain (residues 1-59;
Genbank accession M96995) [52]. P13Kb: p85 subunit of human phosphatidylinositol 3-OH kinase (residues 1-80) [16].
consistently return to their original positions and are
thus quite precisely localized (Fig. 7a). In contrast to the
tight clustering of all 24 structures in the C3G complex,
the arginine side chain and the carboxylate groups are
less well localized in the c-Crk/Sos complex (Fig. 7b).
The disorder in the arginine side chain is probably
underestimated by this method, as the electron density
shows evidence for an alternative arginine conformation
(not revealed by the limited radius of convergence of the
refinement method) that makes fewer hydrogen bonds
than those depicted in Fig. 7b.
These results demonstrate that the arginine side chain in
the crystal structure does not hydrogen bond with the
side chain of Glu149 (Fig. 7b). Most interestingly, in the
SH3 domain of the viral oncogene product v-Crk, the
residue at the corresponding position is a glycine (Fig. 8).
This SH3 domain has a 13-fold lower binding affinity for
the C3G peptide (Kd=2 5 .5 pLM) than does the c-Crk
SH3-N domain (Kd=l. 9 ,uM) and also does not discrim-
inate between lysine and arginine at the P-3 position
(Table 1). The comparison of the binding modes of
lysine and arginine (Fig. 7) explains this effect very
nicely, as the loss of Glu149 in v-Crk removes a side
chain that interacts with lysine, but not with arginine.
Likewise, the loss of Glu148 in Crkl (Fig. 8), which does
discriminate between lysine and arginine [10], does not
affect peptide binding because this side chain points away
from the binding site (Fig. 7).
Why does the lysine-containing C3G peptide bind so
much more strongly to the c-Crk SH3 domain than to
other SH3 domains such as Grb2? Ionic interactions do
not often make a major contribution to protein stability,
and are thought to be destabilizing in most situations, in
contrast to hydrophobic packing interactions [39].
However, the involvement of charged side chains in pro-
tein complexes can assure specificity in the interaction,
because the energetic penalty for desolvating the ions has
to be compensated for, at least partially, through ion-
pairing and hydrogen bonding. In comparing the affinity
of the C3G peptide for c-Crk and other SH3 domains,
the extent to which the SH3 domain can compensate for
the desolvation of lysine versus arginine has to be consid-
ered. The difference in binding affinity between the C3G
peptide and a variant that contains a single Lys-Arg
mutation corresponds to -1.3 kcal mo 1-1 (Table 1),
which is roughly equivalent to the loss of a hydrogen
bond [40]. For c-Crk, we observe three strong hydrogen
bonds for lysine in the C3G peptide, and two or three
less optimal hydrogen bonds for arginine in the Sos pep-
tide (Fig. 7). Analysis of an extensive list of SH3
sequences shows that the presence of three acidic residues
in the RT loop that can form the lysine-specific interac-
tion is unique to c-Crk and its close relatives (see Fig. 8
for an alignment of a limited set of sequences). In the
case of arginine binding to SH3 domains with one or
two acidic side chains in the RT loop, the guanidinium
group of the arginine is able to make two or three hydro-
gen-bonding interactions with these side chains [21].
Lysine, on the other hand, cannot make multiple hydro-
gen-bonding interactions unless the carboxylate groups
approach each other closely and in a relatively precise
orientation, as seen in the c-Crk SH3 domain structure.
Biological implications
Src homology 3 (SH3) and SH2 domains are small
modular units that are important for the genera-
tion of protein-protein interactions in cellular sig-
nal transduction pathways. SH3 domains bind to
proline-rich peptides. Binding is mediated by a
relatively small interaction surface, and without
the benefit of the multiple hydrogen bonds that
anchor phosphotyrosine side chains to SH2
domains. SH3-peptide interactions are therefore
I II
bbbbbbb RT loop bbbbb n-src loop bbbbb distal bbbbb 3,0 bbbb
Crk-N AEY VRALFDF NGNDEEDLPFKKGDI LRIRD KP EEQ WWNAE DSE G KRGMI PVPYV EKYR
v-Crk VEY VRALFDF KGNDDGDLPFKKGDI LKIRD KP EEQ WWNAE DMD G KRGMI PVPYV EKC
Crkl LEY VRTLYDF PGNDAEDLPFKKGEI LVIIE KP EEQ WWSAR NKD G RVGMI PVPYV EKL
Nck-N AEEVV VVAKFDY VAQQEQELDIKKNER LWLLD D SKS WWRVR NSM N KTGFV PSNYV ERKN SA
Lck DNL VIALHSY EPSHDGDLGFEKGEQ LRILE Q SGE WWKAQ SLTTG QEGFE PFNFV AKA
Fyn VTL FVALYDY EARTGDDLSFHKGEK FQILN SS EGD WWEAR SLTTG ETGYI PSNYV APVD
Spec DETGKEL VLALYDY QEKSPREVTMKKGDI LTLLN ST NKD WWKVE VN D RQGFV PAAYV KKLD
Abl L FVALYDF VASGDNTLSITKGEK LRVLG YNH NGE WCEAQ TKN GQGWV PSNYI TPVN SL
Grb2-N ME AIAKYDF KATADDELSFKRGDI LKVLN EEC DQN WYKAE LN G KDGFI PKNYI EMKP HP
PI3Kb MSAEGYQ YRALYDY KKEREEDIDLHLGDI LTVNK GSLVALGFSDGQEARPEEIG WLNGY NETTG ERGDF PGTYV EYIG RK
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of low affinity (1 p.M in the best cases). The con-
served framework of side chains on the SH3 sur-
face allows for efficient packing with polyproline
type II helices, but the reliance on hydrophobic
interactions, which are generally less specific than
those involving hydrogen bond formation, results
in SH3-peptide recognition being promiscuous.
Ion-pairing interactions between the peptide and
the SH3 domain have been shown previously to
select one of two possible orientations of a pep-
tide, with corresponding restrictions on the place-
ment of non-proline residues [18-21]. However, in
the general case where arginine residues in the
peptide are used to form the ion pairs, the pres-
ence of acidic patches on the surfaces of a large
set of SH3 domains results in the binding of par-
ticular peptides, such as those from the guanine
nucleotide exchange factor Sos, to a large number
of SH3 domains with comparable affinity.
For many SH3 domains it may be the case that
biological specificity is only achieved by exploit-
ing multiple binding sites and by tertiary inter-
actions with the parent protein and its target.
However, proline-rich peptides from another gua-
nine nucleotide exchange factor, C3G, are able to
distinguish the c-Crk SH3 domain from a number
of others by using a lysine rather than an arginine
at the key P 3 position in the polyproline helix.
The lysine-specific binding site seen in the c-Crk
SH3 domain described here is extremely rare in
protein structures, and it may have evolved in the
SH3 domain because the limited sites of variabil-
ity on the proline-rich peptide make it advanta-
geous to discriminate between lysine and arginine
while exploiting electrostatic complementarity. As
specific interactions between other SH3 domains
and target peptides are discovered, subtle yet pre-
cise differences in their interactions may again
turn out to be crucial for discriminating between
SH3-binding sites.
Materials and methods
Expression and purification
The DNA sequence coding for the N-terminal SH3 domain of
c-Crk was amplified using the polymerase chain reaction
(PCR) with a mouse cDNA clone as a template. The amplified.
fragment encodes 58 residues (134-191) of the mouse c-Crk
protein plus an initial methionine. This fragment was cloned
into the Escherichia coli expression vector pET3a (Novagen).
Cultures of E. coli BL2 1 (DE3) strains, transformed by the
resulting plasmid, were grown at 37°C in LB medium supple-
mented with 100 gig ml-1 ampicillin [41]. After 3 h of induc-
tion with isopropyl-thio-3-D-galactoside (IPTG) at 37°C, the
cell pellet from 1 1 of culture was resuspended in 100 ml of
standard buffer (20 mM Tris, pH 8.0, 2 mM dithiothreitol,
0.5 mM EDTA) supplemented with 50 gig rm1-1 leupeptin
(Boehringer-Mannheim, Germany) and 1% (v/v) aprotinin
(Sigma). Cells were lysed by sonication on ice and the suspen-
sion was centrifuged for 20 min at 15000 rpm at 4C in a
Beckmann JA17 rotor, and the clear supernatant was reco-
vered. Protein purification proceeded along standard lines
using a Q-Sepharose Fast Flow column (Pharmacia), a mono-
Q HR 10/10 column (Pharmacia) and a Superdex75 HiLoad
16/60 column (Pharmacia). The protein was concentrated to
85 mg ml-' using ultrafiltration (Amicon). SDS-PAGE elec-
trophoresis using Coomassie blue staining reveals a single band
at the expected molecular weight (7 kDa).
Crystallization with peptides
The two peptides used in this work, C3G (PPPALPPKKR) and
Sos (PPPVPPRRRR) were synthesized as part of a project to
determine the peptide binding specificity of the c-Crk SH3
domain [10] (B Knudsen et al., unpublished data), and made
available to us for crystallization. Peptides were synthesized by
the Peptide Technology Group at Amgen Boulder Inc.,
Boulder, CO, using conventional technology. The peptides
were purified by high-performance liquid chromatography and
lyophilized prior to resuspension in buffer for crystallization, and
their identities were confirmed by mass spectroscopy. Cry-
stallization of the c-Crk SH3-N/peptide complexes was per-
formed using the hanging drop technique at 21°C. The best
crystals were obtained by vapor diffusion against a reservoir solu-
tion containing 0.1 M sodium acetate pH 4.6, 0.2 M ammo-
nium acetate, 28-32% polyethylene glycol (PEG) 4K. The
c-Crk SH3-N protein solution (1 Ril at 85 mg ml-1, 12 mM)
was first mixed with 1.5 l of C3G or Sos peptide solution (10
mg ml-', 9.0 mM, in water) and then mixed with 1.0 p1l of
reservoir solution. Crystals were reproducibly obtained over a
period of several days, with final dimensions of 2.0x0.2x0.2 mm3
in the best cases. 'Interestingly, all attempts to obtain crystals in
the absence of high-affinity peptides were unsuccessful.
Crystals of c-Crk SH3 in complex with either peptide were
obtained in the same crystal system (tetragonal P4 1; a=47.2 A,
c=29.4A for the C3G complex and a=47.4 A, c=29.5 A for
the Sos complex). X-ray diffraction data were measured using a
Rigaku R-AXIS IIC imaging plate area detector, mounted on
a Rigaku RU200 rotating anode X-ray generator. Each data
set was collected from a single crystal flash-frozen at -160°C.
The crystals were cryo-protected by transferring them to a
solution containing 0.1 M sodium acetate, pH 4.6, 0.2 M
ammonium acetate, 35% PEG 4K supplemented with 10%
glycerol. Data for c-CrkSH3/C3G were collected using a crys-
tal-to-detector distance of 60 mm and exposure times of
10 min for 2° oscillations (for data to 1.50 A spacings) and a
total of 80 frames was collected. Data for the Sos complex were
collected with a crystal-to-detector distance of 100 mm (for
data to 1.90 A spacings), exposures of 60 min and 3° oscilla-
tions. Data processing and reduction were carried out with the
HKL, DENZO and SCALEPACK programs (Z Otwinowski
and W Minor, unpublished programs). Statistics for the final
data sets are given in Table 3.
Structure determination and refinement
The structure of the c-Crk/C3G complex was determined by
molecular replacement [42] using the X-PLOR program [43].
The crystal structures of two SH3 domains, the Lck SH3
domain [24] and the Nck N-terminal SH3 domain (X Wu
and J Kuriyan, unpublished data), were independently used as
search models. No model for bound peptide was included in
the molecular replacement calculations. Rotation function
searches followed by Patterson correlation refinement [42]
gave similar results with either the Lck or the Nck SH3
domain as the model. The highest peak in the rotation search
corresponded to an orientation of the model that gave a strong
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Table 3. Statistics for the data collection and refinement.
c-CrkSH3/ c-CrkSH3/
C3G Sos
Data collection statistics
Space group P41 P41
Unit cell a=47.2A, a = 47.4A,
c=29.4A c=29.5A
Resolution (A) 20-1.50 20-1.90
No. of observed reflections 66 868 50 442
No. of unique reflections 10512 5289
Completeness of data to 1.90A 89.1% 95.5%
Completeness of data between 1.90-1.50A 73.8% -
I/a(l) in all shells 29.6 21.9
l/(a(I) in outer shell 16.6 5.4
Rsym 4.0% 9.4%
Refinement statistics
Rcryst [F >2o(F)] 17.4% 18.3%
(6.0-1.50 A) (6.0-1.90 A)
No. of unique reflections [FI>2a(F)] 7667 4616
No. of molecules in asymmetric unit 1 1
No. of non-hydrogen atoms in final model 664 608
No. of water molecules in final model 119 68
Rms deviation of bond lengths (A) 0.012 0.011
Rms deviation of bond angles () 1.9 1.9
signal in translation functions calculated using P41 (but not
P43) as the space group. Consistent results were obtained
using various resolution ranges. The peak in the translation
function was 10o. above the mean value when using data from
8.0-2.5 A, and the next highest peak was below 5o. This
solution was used for further structural refinement.
The structure was refined following standard procedures using
X-PLOR [44] and O [45]. Charges for the side-chain atoms of
lysine, arginine, glutamate and aspartate were set to zero, and
thus the refinement procedure is not expected to introduce any
bias towards ion-pairing interactions. Rigid-body refinement
in X-PLOR of the translation-function solution reduced the
R-value from 50.2% to 49.7% (all data with I F >2u,
8.0-2.5 A). This model was then subjected to 200 cycles of
conjugate-gradient optimization, which reduced the R-value
to 29.7% (8.0-2.5 A). Electron-density maps calculated at this
stage were interpretable in terms of the sequence of c-Crk
SH3-N, and strong density. corresponding to the bound pep-
tide was visible. In particular, very strong density was observed
for the side chain of Lys8 in the peptide, as well as for Leu5
and Pro2. The unambiguous placement of the lysine and
leucine side chains made it obvious that the peptide orientation
was reversed relative to that seen previously in the p85 , Abl
and Fyn SH3 domains [16,17], and a model for peptide
residues 1-8 was built into the density. The atomic model for
Lck SH3 [24] was modified to correspond to the sequence of
c-Crk SH3-N, and rebuilt based on the electron-density map.
Several cycles of model building and crystallographic refine-
ment, including simulated annealing, resulted in a final model
that has an R-value of 17.4% (for data between 6.0 A and 1.5
A resolution) with very good stereochemistry (see Table 3).
The model contains 57 residues of c-Crk SH3-N (residues
134-190), nine residues of the peptide (no electron density is
seen for the terminal arginine) and 119 water molecules.
The refined structure of the c-Crk SH3-N domain (with pep-
tide removed) was used to initiate refinement against data for
the c-Crk SH3-N/Sos complex, as the two crystal forms are
isomorphous. During the initial rigid-body refinement, the
R-value dropped significantly from 51.8% to 33.6%, using data
from 6.0 A to 1.9 A spacings. Positional refinement reduced
the R-value further, to 26.8%. An ( Fo I - Fc ) electron-den-
sity map, with model phases, revealed the presence of bound
peptide. In contrast to the C3G complex, where the density
for the side chain of Lys8 was the strongest feature in the elec-
tron-density map, the arginine side chain in the Sos peptide
does not have particularly strong density. Nevertheless, the
placement of the peptide residues was unambiguous.
Straightforward model building and refinement yielded the
final model which contains 57 residues of c-Crk SH3-N
(residues 134-190), eight residues of Sos (residues 1-8; no
electron density is present for the last two arginine residues)
and 68 water molecules. The Arg8 side chain of Sos is not visi-
ble in electron-density maps, and so an alanine residue was
built at that position. The final R-value is 18.3 % (using data
from 6.0-1.9 A, see Table 3).
The atomic coordinates and structure factors have been
deposited in the Brookhaven protein databank. Coordinates
are also available directly from the authors by e-mail
(wux~rockefeller.edu).
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